Martin Demarchi - Concepedia

Author

Martin Demarchi

Inserm ORCID

Also Known As

C. Delbaldo, M DEMARCHI, M Demarchi, M. Demarchi, M.F. Demarchi, Martin Demarchi, Martin Frederico Demarchi

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Inserm Centre Hospitalier Universitaire de Besançon Université de franche-comté Université de technologie de belfort-montbéliard Methodology and Quality of Life Unit in Oncology

About

Martin Demarchi is an author at Inserm specializing in medicine, pathology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	783
2	Engineering	1	1	74
3	Natural Sciences	1	1	41
4	Biochemistry	1	1	41
5	Cell Biology	1	1	42

Martin Demarchi

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study Caroline Charlier, Élodie Perrodeau, Alexandre Leclercq, The Lancet Infectious Diseases Prognostic FactorsFoodborne IllnessClinical FeaturesMicrobiologyInfection Control	2017	556
A randomized, placebo-controlled phase III trial of masitinib plus gemcitabine in the treatment of advanced pancreatic cancer G. Deplanque, Martin Demarchi, Mohamed Hebbar, Annals of Oncology	2015	92
Determination of sugar cane herbicides in soil and soil treated with sugar cane vinasse by solid-phase extraction and HPLC-UV Carolina Lourencetti, Martin Demarchi, Márcio Garcia Ribeiro Talanta Agricultural ChemistryEngineeringEnvironmental EngineeringCrop ProtectionAnalytical Chemistry	2008	74
Discordance in early breast cancer for tumour grade, Estrogen Receptor, Progesteron Receptors and Human Epidermal Receptor-2 status between core needle biopsy and surgical excisional primary tumour Véronique Lorgis, M.-P. Algros, Cristian Villanueva, The Breast	2011	74
Computerized physician order entry of injectable antineoplastic drugs: An epidemiologic study of prescribing medication errors Virginie Nerich, Samuel Limat, Martin Demarchi, International Journal of Medical Informatics MedicineDrug Information SystemPharmacoepidemiologyPatient SafetyOutcomes Research	2010	62
DCF (docetaxel, cisplatin and 5-fluorouracil) chemotherapy is a promising treatment for recurrent advanced squamous cell anal carcinoma Stéfano Kim, Marine Jary, Luigi Mansi, Annals of Oncology Promising TreatmentGastrointestinal OncologyMedicineMetronomic TherapyPathology	2013	54
Impact of STAT3 Phosphorylation on the Clinical Effectiveness of Anti-EGFR–Based Therapy in Patients With Metastatic Colorectal Cancer Erion Dobi, Franck Monnien, Stéfano Kim, Clinical Colorectal Cancer Anti-egfr–based TherapyMedicineColorectal CancerPathologyCancer Cell Biology	2012	42
An APCI LC‐MS/MS method for routine determination of capecitabine and its metabolites in human plasma Damien Montange, Michel Bérard, Martin Demarchi, Journal of Mass Spectrometry Routine DeterminationMedicinal ChemistryBioanalysisAnalytical ChemistryLiquid Chromatography	2010	41
Intra-operative intra-peritoneal chemotherapy with cisplatin in patients with peritoneal carcinomatosis of ovarian cancer Emmanuel Guardiola, Delphine Delroeux, Bruno Heyd, World Journal of Surgical Oncology	2009	33
Economic impact of prescribing error prevention with computerized physician order entry of injectable antineoplastic drugs Virginie Nerich, Christophe Borg, Cristian Villanueva, Journal of Oncology Pharmacy Practice	2012	28

Page 1